MET Amplification and Response to MET Inhibitors in Stage IV Lung Adenocarcinoma.

Suryavanshi, Moushumi; Shah, Aekta; Kumar, Dushyant; Panigrahi, Manoj K; Metha, Anurag; Batra, Ullas

Suryavanshi, Moushumi; Shah, Aekta; Kumar, Dushyant; Panigrahi, Manoj K; Metha, Anurag; Batra, Ullas.

Oncol Res Treat ; 40(4): 198-202, 2017.

Article in En | MEDLINE | ID: mdl-28324883

Subject(s)

Adenocarcinoma/drug therapy; Adenocarcinoma/metabolism; Lung Neoplasms/drug therapy; Lung Neoplasms/metabolism; Protein Kinase Inhibitors/therapeutic use; Proto-Oncogene Proteins c-met/antagonists & inhibitors; Proto-Oncogene Proteins c-met/metabolism; Adenocarcinoma/pathology; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/therapeutic use; Biomarkers, Tumor/antagonists & inhibitors; Biomarkers, Tumor/metabolism; Female; Humans; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Staging; Proto-Oncogene Proteins c-met/genetics; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Adenocarcinoma / Proto-Oncogene Proteins c-met / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google